Zhi-xin Xu

发表

Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab.

F. Barkhof, W. Klunk, L. Thurfjell, 2012, Archives of neurology.

Effect of peginterferon alfa‐2a (40KD) on cytochrome P450 isoenzyme activity

J. Grippo, Zhi-xin Xu, B. Brennan, 2013, British journal of clinical pharmacology.

Evaluation of the absolute bioavailability of pegylated interferon alfa-2a after subcutaneous administration to healthy male volunteers: an open-label, randomized, parallel-group study.

J. Grippo, Zhi-xin Xu, B. Brennan, 2012, Clinical therapeutics.

The effect of stellate ganglion block on sleeping in patients with intractable insomnia : cases report with successful treatment outcome

Zhi-xin Xu, M. Yu, Peng Sun, 2018 .

PKC isoforms and other signaling proteins involved in surfactant secretion in developing rat type II cells.

Zhi-xin Xu, S. Rooney, L. Gobran, 1998, American journal of physiology. Lung cellular and molecular physiology.

Pharmacodynamic Modeling of Prednisolone Effects on Natural Killer Cell Trafficking

W. Jusko, Mi-Jeong Lee, Zhi-xin Xu, 1995, Pharmaceutical Research.

[Study on the level of specific IgG, IgG1 and IgE during anaphylactic shock in sheep induced by Echinococcus granulosus].

Zhi-xin Xu, H. Wen, Hong Zheng, 2003, Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases.

First-in-Human, Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of RO5126766, a First-in-Class Dual MEK/RAF Inhibitor in Patients with Solid Tumors

F. Rojo, J. Albanell, J. Soria, 2012, Clinical Cancer Research.

Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors.

James X. Song, A. Tolcher, G. Shapiro, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Third-generation model for corticosteroid pharmacodynamics: Roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver

Richard R. Almon, Debra C. DuBois, William J. Jusko, 1995, Journal of Pharmacokinetics and Biopharmaceutics.

Differential dynamics of receptor down-regulation and tyrosine aminotransferase induction following glucocorticoid treatment

D. DuBois, R. Almon, W. Jusko, 1995, The Journal of Steroid Biochemistry and Molecular Biology.

Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor RO4987655 (CH4987655) in Patients with Advanced Solid Tumors

J. Schellens, R. Rueger, M. Scheulen, 2012, Clinical Cancer Research.

Cancer Therapy: Clinical Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor RO4987655 (CH4987655) in Patients with Advanced Solid Tumors

J. Schellens, R. Rueger, M. Scheulen, 2012 .

Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C.

Zhi-xin Xu, W. Fung, P Bailon, 2001, Bioconjugate chemistry.

[Pathologic observation on animal model of silicosis].

Zhi-xin Xu, O. Bai, Hao Wen, 2011, Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases.

Influence of dexamethasone on the lipid distribution of newly synthesized fatty acids in fetal rat lung.

Zhi-xin Xu, S. Rooney, Z. Xu, 1989, Biochimica et biophysica acta.

Cancer Therapy: Clinical Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor RO4987655 (CH4987655) in Patients with Advanced Solid Tumors

J. Schellens, R. Rueger, M. Scheulen, 2012 .